
Etanercept prevents histopathological damage after spinal cord injury in rats
Author(s) -
Aşkın Esen Hastürk,
Çağdaş Baran,
Erdal Yı́lmaz,
Murat Arıkan,
Güray Toğral,
Nazlı Hayırlı,
Berrin İmge Ergüder,
Oya Evirgen
Publication year - 2018
Publication title -
asian journal of neurosurgery
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2248-9614
DOI - 10.4103/ajns.ajns_307_16
Subject(s) - medicine , malondialdehyde , superoxide dismutase , spinal cord , etanercept , spinal cord injury , neuroprotection , tumor necrosis factor alpha , necrosis , adenosine deaminase , anesthesia , pathology , endocrinology , oxidative stress , adenosine , psychiatry
The aim of our study is to assess the neuroprotective effects of the tumor necrosis factor alpha (TNF-α) inhibitor etanercept (ETA) on histopathological and biochemical changes following spinal cord injury (SCI).